Breaking News on Supplements & Nutrition - North AmericaEU edition
Products > Supplier info center
Request free information:
Please note that any information that you supply is protected by our Privacy and Cookies Policy.
Access to all documents and request for further information are available to all users at no cost. In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information may be shared with the owners of that document or information.
Lonza Ltd
About Lonza
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Products and services span its customers’ needs from research to final product manufacture. It is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is also the world leader in microbial control providing innovative, chemistry-based and related solutions to destroy or to selectively inhibit the growth of harmful microorganisms. Its activities encompass the areas of water treatment, personal care, health and hygiene, industrial preservation, materials protection, and wood treatment. In addition, Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Furthermore, the company is a leading provider of value chemical and biotech ingredients to the nutrition and agro markets.
Lonza is headquartered in Basel, Switzerland and is listed on the SIX Swiss Exchange and secondary listed on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza is not subject to the SGX-ST’s continuing listing requirements. Lonza is subject to the listing rules of the SIX Swiss Exchange, which do not have specific requirements equivalent to the listing rules of the SGX-ST in respect of interested person transactions, acquisition and realizations, and delisting. In 2011, the company had sales of CHF 2.692 billion. Further information can be found at www.lonza.com .
For the nutrition market Lonza offers a portfolio of branded health ingredients:
Carnipure™ is high quality L-carnitine, a nutrient essential for energy metabolism. Extensive scientific research shows that Carnipure™ can play a beneficial role in many areas of health, such as sports nutrition, weight management, infant nutrition, male fertility, and pregnancy.
Made from naturally occurring microalgae, DHAid™ is a purely vegetarian source of omega-3 DHA. Health benefits of DHAid™ include the support of brain development and function as well as heart and eye health.
ResistAid™ is a natural proprietary immune support ingredient that is formulated to deliver triple action immune benefits year round. Made from North American larch trees, it consists of arabinogalactan and bioactive flavonoids, which have antioxidant capacity.
The Memree™ brand covers a line of products that contain high quality, soy-based phosphatidylserine. Phosphatidylserine is an important structural component of cell membranes and is found in concentrated amounts in brain cells. Products in the Memree™ line include MemreePS™ for cognitive health and MemreePlus™ for cognitive health, stress reduction and exercise recovery applications.
Lonza is the leading supplier of vitamin B3 in the form of Niacin and Niacinamide. Vitamin B3 is an essential vitamin needed for protein, carbohydrate and fat metabolism. Additionally, Niacin has been shown to support healthy levels of HDL. Vitamin B3 is widely used in dietary supplements and functional foods and beverages.